{"id":310706,"date":"2019-01-02T07:21:02","date_gmt":"2019-01-02T07:21:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=310706"},"modified":"2019-01-02T07:21:02","modified_gmt":"2019-01-02T07:21:02","slug":"antiviral-drugs-poised-to-attain-high-growth-of-6267-with-top-industry-players-gilead-sciences-inc-hoffmannla-roche-ltd-glaxosmithkline-plc-abbott-laboratories-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/antiviral-drugs-poised-to-attain-high-growth-of-6267-with-top-industry-players-gilead-sciences-inc-hoffmannla-roche-ltd-glaxosmithkline-plc-abbott-laboratories-by-2023_310706.html","title":{"rendered":"Anti-Viral Drugs Poised To Attain High Growth of $62.67 With Top Industry Players: Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories by 2023"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/01\/1546428267.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"https:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2019\/01\/1546428267.jpeg\" alt=\"\" width=\"225\" height=\"\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">MRFR is the Leading Brand in The Research Company who Recently Published Anti-Viral Drugs \u00a0Market Research Report which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2022.<\/div>\n<p><strong>Market Scenario:<\/strong><\/p>\n<p>Viruses are the ultimate parasites as they derive nutrition from the host cell and also hijack and direct its metabolic machinery to synthesize new virus particles. Viruses can live and replicate only inside host body. Anti-viral drugs are specifically used to treat viral infections and act mostly by inhibiting their target viruses. The growth of antiviral drugs market is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO estimates 36.7 million people are suffering from HIV\/AIDS worldwide with 1.1 million deaths of AIDS-related illnesses in 2015.<\/p>\n<p><strong><em>Get Sample Copy @ <\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/sample_request\/2454\"><em>https:\/\/www.marketresearchfuture.com\/sample_request\/2454<\/em><\/a><\/p>\n<p>The market for anti-viral drugs is expected to reach $62.67 billion by the end of the forecast period growing at a CAGR of 6.9%.<\/p>\n<p><strong>Key Players for Global Anti-Viral Drugs Market:<\/strong><\/p>\n<ul>\n<li>Johnson &amp; Johnson,<\/li>\n<li>Merck &amp; Co. Inc.,<\/li>\n<li>Gilead Sciences Inc.,<\/li>\n<li>Hoffmann-La Roche Ltd.,<\/li>\n<li>GlaxoSmithKline Plc,<\/li>\n<li>Abbott Laboratories,<\/li>\n<li>Novartis International AG,<\/li>\n<li>Astra Zeneca AB,<\/li>\n<li>Cipla Inc.<\/li>\n<\/ul>\n<p><strong>Market Segments:<br \/> <\/strong>Global Anti-viral drugs market has been segmented on the basis of application, which comprises hepatitis, HIV\/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into&nbsp;nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.<\/p>\n<p><strong>Intended Audience<\/strong><\/p>\n<ul>\n<li>Anti-viral drugs Manufacturers<\/li>\n<li>Anti-viral drugs Suppliers<\/li>\n<li>Private Research Laboratories<\/li>\n<li>Research and Development (R&amp;D) Companies<\/li>\n<li>Market Research and Consulting Service Providers<\/li>\n<li>Government Research Laboratories<\/li>\n<li>Contract Manufacturing Organizations<\/li>\n<\/ul>\n<p><strong>Regional Analysis<\/strong><\/p>\n<p>Globally America is the largest market for anti-viral drugs. North America dominated the market for anti-viral drugs with a share of greater than 30%. &nbsp;Europe is the second-largest market for anti-viral drugs. Asia pacific region is expected to be fastest growing region in anti-viral drugs market.<\/p>\n<p><strong><em>Browse Complete 84 Pages Premium Research Report Enabled with Respective Tables and Figures at @ <\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/reports\/anti-viral-drugs-market-2454\"><em>https:\/\/www.marketresearchfuture.com\/reports\/anti-viral-drugs-market-2454<\/em><\/a><\/p>\n<p><strong>Table Of Contents<\/strong><\/p>\n<p><strong>1 Introduction<\/strong><\/p>\n<p>1.1 Definition<\/p>\n<p>1.2 Scope Of Study<\/p>\n<p>1.3 Research Objective<\/p>\n<p>1.4 Assumptions &amp; Limitations<\/p>\n<p>1.5 Market Structure:<\/p>\n<p><strong>2 Research Methodology<\/strong><\/p>\n<p>2.1 Research Process<\/p>\n<p>2.2 Primary Research<\/p>\n<p>2.3 Secondary Research<\/p>\n<p><strong>3 Market Dynamics<\/strong><\/p>\n<p>3.1 Drivers<\/p>\n<p>3.2 Restraints<\/p>\n<p>3.3 Opportunities<\/p>\n<p>3.4 Challenges<\/p>\n<p>3.5 Macroeconomic Indicators<\/p>\n<p><strong>4 Market Factor Analysis<\/strong><\/p>\n<p>4.1 Porter&rsquo;s Five Forces Model<\/p>\n<p>4.1.1 Bargaining Power Of Suppliers<\/p>\n<p>4.1.2 Bargaining Power Of Customer<\/p>\n<p>4.1.3 Intensity Of Competitor&rsquo;s<\/p>\n<p>4.1.4 Threat Of New Entrants<\/p>\n<p><strong>&#8230;Continued!<\/strong><\/p>\n<p><strong><em>Send an Enquiry @ <\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.marketresearchfuture.com\/enquiry\/2454\"><em>https:\/\/www.marketresearchfuture.com\/enquiry\/2454<\/em><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong><br \/> About US:<\/strong><\/p>\n<p>Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research &amp; Consulting Services.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Market Research Future<br \/><strong>Contact Person:<\/strong> Abhishek Sawant<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=antiviral-drugs-poised-to-attain-high-growth-of-6267-with-top-industry-players-gilead-sciences-inc-hoffmannla-roche-ltd-glaxosmithkline-plc-abbott-laboratories-by-2023&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9312<br \/><strong>Address:<\/strong>Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar  <br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketresearchfuture.com\/reports\/anti-viral-drugs-market-2454\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketresearchfuture.com\/reports\/anti-viral-drugs-market-2454<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketresearchfuture.com\/reports\/anti-viral-drugs-market-2454\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=antiviral-drugs-poised-to-attain-high-growth-of-6267-with-top-industry-players-gilead-sciences-inc-hoffmannla-roche-ltd-glaxosmithkline-plc-abbott-laboratories-by-2023\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MRFR is the Leading Brand in The Research Company who Recently Published Anti-Viral Drugs \u00a0Market Research Report which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2022. Market Scenario: Viruses are &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/antiviral-drugs-poised-to-attain-high-growth-of-6267-with-top-industry-players-gilead-sciences-inc-hoffmannla-roche-ltd-glaxosmithkline-plc-abbott-laboratories-by-2023_310706.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-310706","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/310706","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=310706"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/310706\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=310706"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=310706"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=310706"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}